• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PPD’s Jay Dixon elected to NCBIO board

PPD’s Jay Dixon elected to NCBIO board

November 10, 2015
CenterWatch Staff

Jay Dixon, senior vice president of global quality and compliance at PPD, has been elected to the board of directors of the North Carolina Biosciences Organization (NCBIO), the trade association for the state’s bioscience industry.

“Jay brings a wealth of experience to the board, particularly in the area of clinical development,” said NCBIO President Sam Taylor. “Jay has worked with NCBIO on a number of important projects and we look forward to bringing his experience and insights to the NCBIO board of directors.”

Dixon, a seasoned executive with nearly 30 years of experience in the CRO, pharmaceutical and biotechnology industries, joins 14 bioscience industry leaders who were recently elected or re-elected to three-year terms on the board.

At PPD, Dixon is responsible for overseeing strategy and execution of the company’s global quality function, including clinical and laboratory quality assurance, regulatory compliance, risk management, policy and procedure management and quality management systems. He holds a bachelor’s degree in biology from Campbell University.

“With North Carolina as home to PPD’s worldwide headquarters and to thousands of talented professionals helping our clients deliver life-changing medicines, we understand the value of effective public policy in nurturing the state’s research ecosystem,” said Dixon. “NCBIO has been hard at work advancing this goal for more than 20 years. I’m honored to serve on the board of NCBIO and to support its mission of promoting the growth and development of North Carolina’s biosciences industry.”

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing